National Research Co. (NASDAQ:NRC) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lowered its stake in shares of National Research Co. (NASDAQ:NRCGet Rating) by 31.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,448 shares of the company’s stock after selling 3,455 shares during the period. Victory Capital Management Inc.’s holdings in National Research were worth $285,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Hardy Reed LLC purchased a new position in National Research in the 1st quarter worth about $37,000. Lazard Asset Management LLC acquired a new position in shares of National Research during the 1st quarter worth approximately $49,000. Amalgamated Bank bought a new position in National Research during the 1st quarter worth $90,000. Baker Tilly Wealth Management LLC bought a new stake in shares of National Research during the 1st quarter worth $250,000. Finally, Strs Ohio grew its holdings in shares of National Research by 6.3% during the second quarter. Strs Ohio now owns 6,800 shares of the company’s stock worth $260,000 after purchasing an additional 400 shares during the last quarter. 67.51% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other National Research news, major shareholder Amandla Mk Trust sold 100,000 shares of the company’s stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $38.59, for a total transaction of $3,859,000.00. Following the transaction, the insider now directly owns 4,661,639 shares in the company, valued at $179,892,649.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last ninety days, insiders sold 246,555 shares of company stock worth $9,814,070. 2.00% of the stock is owned by corporate insiders.

National Research Stock Up 1.4 %

Shares of NASDAQ:NRC opened at $38.36 on Thursday. The business has a fifty day moving average price of $38.77 and a two-hundred day moving average price of $36.87. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.31 and a quick ratio of 1.31. The company has a market capitalization of $966.44 million, a PE ratio of 27.80 and a beta of 0.50. National Research Co. has a 1 year low of $30.93 and a 1 year high of $49.30.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 14th. Investors of record on Friday, September 30th were given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend was Thursday, September 29th. National Research’s dividend payout ratio (DPR) is currently 69.57%.

About National Research

(Get Rating)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

See Also

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.